Delivery Order SPE2DB24D6041-SPE2DB24FKBJS
Award Date
8/28/24
Potential Completion Date
8/29/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The $13,590.70 firm fixed price contract has a completion date of July 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,742.54 firm fixed-price contract is for the delivery of MENQUADFI VIAL 0.5ML medical supplies, with an ultimate completion date of April 26, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The contract has a ceiling value of $7,024.80 and an ultimate completion date of September 9, 2024. This award is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This is a delivery order award valued at $82,833.85 from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $7,024.80 firm-fixed-price contract is for the supply of 4565921653 MENQUADFI VIAL 0.5ML medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,107.44 and a period of performance ending on July 17, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4565380014 MENQUADFI VIAL 0.5ML, a medical supply item. The contract has a firm fixed price of $5,561.46 and an ultimate completion date of August 8, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor and supplier to the federal government. The $1,404.96 firm fixed-price contract is for the delivery of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of July 18, 2024. The contract has no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565220495 MENQUADFI VIAL 0.5ML. The contract is a firm fixed-price delivery order with a ceiling value of $3,512.40 and an ultimate completion date of July 23, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, including a $999,999,999 IDC with the DLA Troop...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $92,462.30 firm-fixed-price contract is for the procurement of MENQUADFI VIAL 0.5ML medical products. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...